svima lifur Gúmmí polo like kinase 4 Þjappað Pabbi örvun
Frontiers | Polo-Like Kinase 4's Critical Role in Cancer Development and Strategies for Plk4-Targeted Therapy
Figure 2 from Polo-like kinase (PLK) inhibitors in preclinical and early clinical development in oncology. | Semantic Scholar
Targeting Polo-Like Kinases: A Promising Therapeutic Approach for Cancer Treatment - ScienceDirect
Polo-like kinase 1 inhibition in NSCLC: mechanism of action and emergi | LCTT
Reversible centriole depletion with an inhibitor of Polo-like kinase 4 | Science
Polo-like kinase in trypanosomes: an odd member out of the Polo family | Open Biology
The family of human Polo-like kinases. Primary structure of human... | Download Scientific Diagram
Frontiers | Polo-Like Kinase 4's Critical Role in Cancer Development and Strategies for Plk4-Targeted Therapy
Autoinhibition and relief mechanism for Polo-like kinase 4 | PNAS
Polo-like kinase inhibitors in hematologic malignancies - ScienceDirect
Reversible centriole depletion with an inhibitor of Polo-like kinase 4 | Science
PLK1 - Wikipedia
Polo-Like Kinase 1 Directs Assembly of the HsCyk-4 RhoGAP/Ect2 RhoGEF Complex to Initiate Cleavage Furrow Formation | PLOS Biology
Cancers | Free Full-Text | The Emerging Role of Polo-Like Kinase 1 in Epithelial-Mesenchymal Transition and Tumor Metastasis | HTML
Down‐regulation of Polo‐like kinase 4 (PLK4) induces G1 arrest via activation of the p38/p53/p21 signaling pathway in bladder cancer - Yang - 2021 - FEBS Open Bio - Wiley Online Library
Polo-like kinase 4 maintains centriolar satellite integrity by phosphorylation of centrosomal protein 131 (CEP131) - Journal of Biological Chemistry
Polo-like kinases: a team that plays throughout mitosis
Polo-like kinase 4: the odd one out of the family | Cell Division | Full Text
Functional Characterization of CFI-400945, a Polo-like Kinase 4 Inhibitor, as a Potential Anticancer Agent: Cancer Cell
Polo-like kinases: conservation and divergence in their functions and regulation | Nature Reviews Molecular Cell Biology
Phase separation of Polo-like kinase 4 by autoactivation and clustering drives centriole biogenesis | Nature Communications
Polo-like Kinase 1 Inhibitors in Human Cancer Therapy: Development and Therapeutic Potential | Journal of Medicinal Chemistry